Preoptimized phage cocktail for use in aerosols against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii: A 3-year prospective intervention study

Phage Cocktail Powder for Pseudomonas aeruginosa Respiratory Infections

(2021) Mengyu Li et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients

(2021) Nannan Wu et al.   Emerging Microbes & Infections

Bacteriophages as a Potential 360-Degree Pathogen Control Strategy

(2021) Maria D’Accolti et al.   Microorganisms

Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance

(2021) Joshua M. Borin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical Phage Microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy

(2021) Daniel Gelman et al.   Lancet Microbe

Mutant and recombinant phages selected from in vitro coevolution conditions overcome phage-resistant Listeria monocytogenes

(2020) Tracey Lee Peters et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

In Vitro Evaluation of a Phage Cocktail Controlling Infections with Escherichia coli

(2020) Imke H. E. Korf et al.   Viruses-Basel

Effective elimination of Staphylococcal contamination from hospital surfaces by a bacteriophage–probiotic sanitation strategy: a monocentric study

(2019) Maria D'Accolti et al.   Microbial Biotechnology

Development of a Biocontrol Method Applying Bacteriophage-Containing Aerosol against Mycobacterium tuberculosis Using the Bacteriophage BTCU-1 and M. smegmatis as Models

(2019) Chun-Chieh Tseng et al.   Microorganisms

Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii

(2019) Yuyu Yuan et al.   VIRUS RESEARCH

Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: A multicentre, prospective, intervention study

(2018) Elisabetta Caselli et al.   PLoS One

Phage Therapy: What Have We Learned?

(2018) Andrzej Górski et al.   Viruses-Basel

Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy

(2018) Frank Oechslin   Viruses-Basel

Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice

(2018) Yunfen Hua et al.   Frontiers in Microbiology

Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents

(2018) Maria D'Accolti et al.   Infection and Drug Resistance

A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models

(2017) Minmin Yen et al.   Nature Communications

Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains

(2017) Li-Kuang Chen et al.   Scientific Reports

Is airborne transmission of Acinetobacter baumannii possible: A prospective molecular epidemiologic study in a tertiary care hospital

(2016) Yusuf Yakupogullari et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections

(2016) James M. Regeimbal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential of a lytic bacteriophage to disruptAcinetobacter baumanniibiofilmsin vitro

(2016) Yannan Liu et al.   Future Microbiology

Application of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care Unit

(2016) Yu-Huai Ho et al.   PLoS One

The safety of polymyxin antibiotics

(2015) Theodoros Kelesidis et al.   Expert Opinion On Drug Safety

Isolation and Host Range of Bacteriophage with Lytic Activity against Methicillin-Resistant Staphylococcus aureus and Potential Use as a Fomite Decontaminant

(2015) Kyle C. Jensen et al.   PLoS One

Phage therapy—constraints and possibilities

(2014) Anders S. Nilsson   UPSALA JOURNAL OF MEDICAL SCIENCES

Antimicrobial resistance inAcinetobacter baumannii: From bench to bedside

(2014) Ming-Feng Lin   World Journal of Clinical Cases

Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital

(2013) Mei Deng et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii

(2013) Li-Kuang Chen et al.   BMC MICROBIOLOGY

Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978

(2013) Meng-Jiun Lai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria

(2011) Meng-Jiun Lai et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Genomic analysis of bacteriophage ϕAB1, a ϕKMV-like virus infecting multidrug-resistant Acinetobacter baumannii

(2011) Kai-Chih Chang et al.   GENOMICS

Room Decontamination with UV Radiation

(2010) William A. Rutala et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Isolation and characterization of ϕAB2: a novel bacteriophage of Acinetobacter baumannii

(2010) Nien-Tsung Lin et al.   RESEARCH IN MICROBIOLOGY

Bacteriophages Reduce Experimental Contamination of Hard Surfaces, Tomato, Spinach, Broccoli, and Ground Beef by Escherichia coli O157:H7

(2008) T. Abuladze et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey

(2008) Meliha Meric et al.   FEMS MICROBIOLOGY LETTERS